The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies

Acta Neurologica Scandinavica

Volumn 96, Issue 6, 1997, Pages 366-371

  Ballard, C ^a   McKeith, I ^b   Burn, D ^b   Harrison, R ^c   O'Brien, J ^b   Lowery, K ^a   Campbell, M ^d   Perry, R ^b   Ince, P ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Bensham Hospital   (United Kingdom)

^d ST NICHOLAS HOSPITAL   (United Kingdom)

Author keywords

Assessment; Dementia with Lewy bodies; Parkinsonism

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRADYKINESIA; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; EXTRAPYRAMIDAL SYMPTOM; FACIAL EXPRESSION; FEMALE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; MUSCLE RIGIDITY; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; RATING SCALE; TREMOR;

EID: 0031434751     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00299.x     Document Type: Article

References (26)

1. BURNS A, LUTHERT P, LEVY R, JACOBY R, LANTOS P. Accuracy of clinical diagnosis of Alzheimer's disease. BMJ 1990: 301: 1026.
2. LENNOX G, LOWA J, MORRELI, K, LANDON M, MAYER RJ. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989: 52: 67-71.
3. KOSAKA K. Diffuse Lewy body disease in Japan. J Neurol 1990: 237: 197-204.
4. GIBB WRG, LUTHERT PJ, JANOTA I, LANTOS PL. Cortical Lewy body dementia: clinical features & classification. J Neurol Neurosurg Psychiatry 1989: 52: 185-92.
5. HANSEN L, SALMON D, GALASKO D et al. The Lewy body variant of Alzheimer's disease: a clinical & pathological entity. Neurol 1990: 40: 1-8.
6. PERRY RH, IRVING D, BLESSED G, FAIRBAIRN A, PERRY EK. A clinically & pathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990: 95: 119-39.
7. DICKSON DW, RUAN D, CRYSTAL, H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light & electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991: 41: 1402-9.
8. BALLARD CG, MOHAN RNC, PATEL A, BANNISTER C. Idiopathic clouding of consciousness - do the patients have cortical Lewy body disease? Int J Ger Psychiatry 1993: 8: 571-6.
9. BALLARD CG, SAAD K, PATEL A et al. The prevalence & phenomenology of psychotic symptoms in dementia sufferers. Int J Ger Psychiatry 1995: 10: 477-86.
10. SHERGILL S, MULLEN E, D'ATH P, KATONA C. What is the clinical prevalence of Lewy body dementia? Int J Ger Psychiatry 1994: 9: 907-12.
11. MCKEITH IG, PERRY RH, FAIRBAIRN AF, JABEEN S, PERRY EK. Operational criteria for senile dementia of Lewy body type. Psychol Med 1992: 22: 911-22.
12. BYRNE EJ, LENNOX G, GOODWIN-AUSTEN LB. Dementia associated with cortical Lewy bodies: proposed diagnostic criteria. Dementia 1991: 2: 283-4.
13. MCKEITH IG, GALASKO D, KOSAKA K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996: 47: 1113-24.
14. GALASKO D, KATZMAN R, SALMON DP, THAL LJ, HANSEN L. Clinical & neuropathological findings in Lewy body dementias. Brain Cogn 1996: 31: 166-75.
15. GNANALINGHAM KK, BYRNE EJ, THORNTON A, SAMBROOK MA, BANNISTER P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997: 62: 243-52.
16. ELLIS RJ, CALIGIURI M, GALASKO D, THAL LJ. Extra-pyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord 1996: 10: 103-14.
17. RICHARDS M, MARDER K, BALL K, DOONEIEF G, MAYEUX R, STERN Y. Inter-rater reliability of extra pyramidal signs in a group assessed for dementia. Arch Neurol 1991: 48: 1147-9.
18. FAHN S, ELTON R, UNIFIED PARKINSON'S DISEASE RATING SCALE COMMITTEE. Unified Parkinson's disease rating scale. In: FAHN S, MARSDEN CD, CALNE D, eds. Recent developments in Parkinson's disease. New York: Macmillan, 1987.
19. HOEHN M, YAHR M. Parkinsonism: symptoms, progression & mortality. Neurology 1967: 17: 427-42.
20. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. Mini mental state examination. J Psychiatr Res 1975: 12: 189-98.
21. BALLARD CG, MCKEITH IG, HARRISON R et al. Depression in dementia with Lewy bodies and Alzheimer's disease. J Affect Disord In Press.
22. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health & Human Services Task Forces on Alzheimer's disease. Neurology 1984: 34: 939-44.
23. MIRRA S, HEYMAN A, MCKEEL D et al. The consortium to establish a registry for Alzheimer's disease (CERAD) Part II: Standardisation of neuropathological assessment of Alzheimer's disease. Neurology 1991: 41: 479-86.
24. SPSS/PC+. Statistical Package for the Social Sciences, Version 3.1 (2nd edition). New York: McGraw-Hill, 1988.
25. FORSELL Y, JORM AF, FRATLIGLION, GRUT M, WINBLAD B. Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatry 1993: 150: 1199-1202.
26. MEGA MS, MASTERMAN DL, BENSON F et al. Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 1996: 47: 1403-9.